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Abstract
Fibroblasts are an integral component of stroma and important source of growth factors and extracellular matrix (ECM).
They play a prominent role in maintaining tissue homeostasis and in wound healing and tumor growth. Notch signaling
regulates biological function in a variety of cells. To elucidate the physiological function of Notch signaling in fibroblasts, we
ablated Notch1 in mouse (Notch1Flox/Flox) embryonic fibroblasts (MEFs). Notch1-deficient (Notch12/2) MEFs displayed faster
growth and motility rate compared to Notch1Flox/Flox MEFs. Such phenotypic changes, however, were reversible by
reconstitution of Notch1 activation via overexpression of the intracellular domain of Notch1 (NICD1) in Notch1-deficient
MEFs. In contrast, constitutive activation of Notch1 signaling by introducing NICD1 into primary human dermal fibroblasts
(FF2441), which caused pan-Notch activation, inhibited cell growth and motility, whereas cellular inhibition was relievable
when the Notch activation was countered with dominant-negative mutant of Master-mind like 1 (DN-MAML-1).
Functionally, ‘‘Notch-activated’’ stromal fibroblasts could inhibit tumor cell growth/invasion. Moreover, Notch activation
induced expression of Wnt-induced secreted proteins-1 (WISP-1/CCN4) in FF2441 cells while deletion of Notch1 in MEFs
resulted in an opposite effect. Notably, WISP-1 suppressed fibroblast proliferation, and was responsible for mediating
Notch1’s inhibitory effect since siRNA-mediated blockade of WISP-1 expression could relieve cell growth inhibition. Notch1-
induced WISP-1 expression appeared to be Wnt11-dependent, but Wnt1-independent. Blockade of Wnt11 expression
resulted in decreased WISP-1 expression and liberated Notch-induced cell growth inhibition. These findings indicated that
inhibition of fibroblast proliferation by Notch pathway activation is mediated, at least in part, through regulating Wnt1-
independent, but Wnt11-dependent WISP-1 expression.
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Introduction
Fibroblasts are key components of the interstitial tissue present
in most organs of the body [1]. They provide a delicately balanced
tissue-specific ECM that partitions the interstitial space between
tissue cells, blood vessels and nerves. Fibroblasts play an important
role in not only supporting tissue architecture, but also partici-
pating in maintenance of tissue homeostasis. Fibroblasts generate
soluble proteins including growth and differentiation factors [2]
and remodelling enzymes, for example, matrix metalloproteases
(MMPs) [3]. These important cells are also involved in synthesis of
ECM, such as collagen and fibronectin [4]. Fibroblasts are known
to play a role in a variety of fibrotic disorders (fibrosis/sclerosis).
Most recently, these cells have gained increasing attention since
they are important components of the supporting stroma in a
variety of solid tumors. Tumors have been characterized as a type
of ‘‘wound that does not heal’’ [5] and are now viewed as ‘‘organs’’
which have a unique microenvironment and specific stromal
compartment. Tumor stroma is comprised of inflammatory cells,
endothelial cells, fibroblasts and ECM. Fibroblasts in tumor tissues
have been termed carcinoma-associated fibroblasts (CAFs), tumor-
associated fibroblasts (TAFs) or cancer-associated fibroblasts
(CAFs) (herein termed as cancer-associated fibroblasts (CAFs))
[6]. CAFs are postulated to promote tumor growth through direct
stimulation of tumor cell proliferation and promotion of tumor
angiogenesis. Fibroblasts, thus, may represent a new therapeutic
target for modulating stroma-associated tissue regeneration and
tumor growth.
In normal adult tissue, resident fibroblasts are maintained in a
relatively quiescent state in which they are involved in slow
turnover of the ECM. Fibroblasts, once activated, undergo a
change in phenotype from the quiescent state to a proliferative and
contractile phenotype termed myofibroblasts (sometimes termed
‘‘activated fibroblasts’’). Myofibroblasts actively produce growth
factors and ECM, display an elongated spindle shape, and express
contractile a–smooth muscle actin (a-SMA) and vimentin [7].
Myofibroblasts can arise from the local, resident fibroblasts or
from circulating mesenchymal precursors/stem cells [8], and even
from epithelial cells via epithelial mesenchymal transition (EMT)
[9].
The Notch signaling pathway is an evolutionarily conserved
signaling cascade that regulates a variety of cellular activities
including proliferation, differentiation, quiescence and death [10].
The Notch receptor and its ligands are transmembrane proteins
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38811
whose signaling requires cell to cell contact between neighboring
cells. Mammals have four Notch receptors (Notch1–4) and five
Notch ligands which fall into two classes: Delta-like (Dll) and
Jagged. Activation of Notch receptors is triggered by interaction
with Notch ligands on adjacent cells. The receptor-ligand binding
results in proteolytic cleavage (by TACE and c-secretase) of NICD
from the membrane bond Notch. NICD subsequently translocates
into the nucleus where it binds to CSL (CBF1/Suppressor of
Hairless/Lag-1)/RBP-Jk and recruits Mastermind-like (MAML)
to form a ternary complex that functions as a transcriptional
activator of Notch target genes. Notch target genes include those
belonging to the Hes and Hey families [11]. The diverse outcome of
Notch activation is dependent on several factors including the
specific timing, the signal strength/gene dosage, and the cell type
and context [12–14].
The role of Notch signaling in fibroblasts is poorly studied. In
this work we investigated the function of Notch signaling in
regulating the cell growth of fibroblasts through in vitro loss-/gain-
of-function approaches. We observed a suppressive effect of
activation of Notch signaling on fibroblast proliferation. We
demonstrated that the inhibitory effect of Notch signaling is
partially mediated by the induction of WISP-1 (CCN4) through a
Wnt11-dependent mechanism in fibroblasts.
Results
Deletion of Notch1 Increases Cell Growth and Motility of
MEFs
To study the physiological function of Notch1 in regulating
fibroblast proliferation and migration, we deleted Notch1 gene in
MEFs isolated from Notch1Flox/Flox mouse embryos at E13.5 by
transducing cells with Cre/lentiviruses versus GFP/lentiviruses
(control) in vitro. Greater than 95% cells were transduced based on
the percentage of GFP-positive cells observed under fluorescence
microscopy. A similar percentage of Cre-positive cells were
achieved using same MOI of Cre/lentiviruses (data not shown).
Knock-down of Notch1 was confirmed by Western blot analysis
(Figure 1A) a week after transduction. A small residual Notch1
expression observed can be explained by non-100% transduction
of MEFs by Cre/lentiviruses. Notch1-deficient (Notch12/2) MEFs
displayed faster cell growth rate as measured by MTT assay
compared to (Notch1Flox/Flox) MEFs (Figure 1B). Cell morphology of
the Notch12/2 MEFs appeared to be unaltered compared to the
Notch1 Flox/Flox MEFs. Cell motility was increased in Notch1-
deficient (Notch12/2) versus Notch1 Flox/Flox MEFs as demonstrated
by recording the trafficking of 15 randomly selected MEFs for
20 hours in an in vitro cell scratch assay (Figure 1C). To
functionally validate the phenotypes observed in Notch1-deficient
(Notch12/2) MEFs, we transduced these cells with NICD (an active
form of Notch1) and GFP (control), respectively, using lentiviral
vectors to reconstitute Notch1 activation. It was observed that
phenotypic changes resulted from Notch1 deletion were reversible
by reconstitution of Notch1 activation (Figure 1D). Notably,
constitutive activation of the Notch1 pathway by NICD overex-
pression even resulted in a significant growth inhibition of Notch1
null MEFs (Notch12/2) compared to wild type of MEFs (Notch1+/+).
This is consistent with what we observed in human dermal
fibroblasts (FF2441) (see below). Overall, these results indicate that
Notch1 signaling in MEFs exerts a suppressive effect on cell
growth and motility.
Constitutive Expression of Exogenous NICD1 Induces
Pan-Notch Activation in Human Fibroblasts
To further study the role of Notch signaling activation on cell
growth of fibroblasts, we aimed to examine the effects of
constitutive Notch1 activation on proliferation of primary human
dermal fibroblasts (FF2441) [14]. To this end, we transduced
FF2441 cells with lentiviral vectors encoding either the GFP
marker gene or the NICD1 gene linked to the GFP marker gene via
internal ribosome entry site (IRES) to express GFP and NICD1
independently [15]. The NICD1–GFP-transduced fibroblasts
simultaneously expressed NICD1 and GFP. At an MOI of 5,
greater than 95% of transduced fibroblasts expressed GFP as
observed by fluorescence microscopy (data not shown). Expression
of NICD1 in transduced FF2441 cells was confirmed by
immunoblotting analysis (Figure 2A). Interestingly, full-length of
Notch1 (,250 Kd) was undetectable in fibroblasts transduced with
GFP/lenti, while detectable in fibroblasts transduced with NICD-
GFP/lenti. It suggested that constitutive expression of exogenous
NICD induced expression of endogenous Notch1. We further
examined the gene profiles of Notch pathway components using
PCR array, we observed a ‘‘self-propagated’’ pan-Notch activation
mechanism induced by enforced expression of exogenous NICD1
in human fibroblasts. We found that constitutive expression of
NICD1 resulted in the up-regulation of gene expression of
multiple Notch pathway components in FF2441 cells, including
ligands (Dll1, Jagged1), receptors (Notch1, 3, and 4), and target genes
(Deltex1, Hes1, Herp2, and Hrt3). The changes in gene induction
were showed in Figure 2B. Thus, hyper-activation of Notch1
pathway caused a pan-Notch signaling activation. These results
thus revealed a ‘‘self-propagated’’ pan-Notch activation mecha-
nism induced by enforced expression of exogenous NICD1 in
human fibroblasts.
Enforced Activation of Notch Pathway Inhibits Human
Fibroblast Proliferation, but Did Not Induce Cell
Apoptosis
We therefore investigated the effect of enforced activation of
Notch1 pathway on cell biology of human fibroblasts. The
constitutive activation of Notch1 by introduction of NICD into
FF2441 cells significantly inhibited cell growth and motility in
human dermal fibroblasts. As determined by MTT assay, cell
proliferation rate of FF2441-NICD1–GFP significantly decreased
compared to FF2441-GFP cells (Figure 3A). However, such a
phenotypic change was reversible when the Notch activation was
countered with DN-MAML-1, an antagonist of Notch pathway
activation. As shown in Figure 3B, cell growth rate of FF2441-
NICD1–GFP-DN-MAML-1 was significantly re-boosted com-
pared to the control (FF2441-NICD1–GFP- Mock). Moreover,
Notch pathway activation retarded the cell growth of FF2441, but
did not induce cell apoptosis as no increase in apoptotic cells was
detectable by TUNEL assay (Figure 3C). Constitutive Notch
pathway activation down-regulated expression a panel of cell cycle
genes, including cyclin D2, cyclin C, cycling E1 and cdk 4, 6, 7 and 8
while up-regulated expression of CDK inhibitor 3 (Table 1),
suggesting that Notch pathway activation results in cell cycle
arrest in human dermal fibroblasts. Similarly, as determined by
time-lapse photography to track and measure cell trafficking in a
modified scratch assay (in vitro wound healing assay), the average
distance traveled by cells toward the middle line of the gap was
smaller at all time points for FF2441-NICD1–GFP compared to
FF2441-GFP cells. Velocity of FF2441-NICD1–GFP versus
FF2441-GFP cells was 14.8+/24.9 (mean +/2 SD) versus
35.9+/26.1 mm/hour (data not shown). These observations
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indicated that constitutive activation of Notch pathway inhibits cell
proliferation and migration in human dermal fibroblasts. Taken
together, the above experiments revealed that deletion of Notch1
increases cell growth and motility in MEFs, while activation of
Notch pathway inhibits cell growth and motility in human dermal
fibroblasts. These data consistently pointed to a role of Notch
signaling in modulating the growth and motility of fibroblast cells.
Status of Notch Signaling Is Correlated with the
Biological Activity of Fibroblasts
To further study the correlation between the Notch pathway
activation and the biological activity of fibroblasts, we examined
the status of Notch signaling in cultured, proliferating FF2441,
which were basically ‘‘activated’’ due to stimulation of serum and
growth factors in the culture medium, versus quiescent FF2441
cells, which were induced by cell-contact inhibition and serum
starvation. The expression of Notch receptors, ligands and known
target genes (including Hes and Hey) were analyzed by the RTu
ProfilerTM PCR Array system. None of the Notch signaling
pathway genes was significantly expressed in the proliferating
fibroblasts. In drastic contrast, the expression of Dll-1, Jagged-2,
Notch1, Notch-3, Notch-4, TACE (ADAM-17) and Hey-1 were
significantly up-regulated (.1.5-fold) in quiescent fibroblasts
(Table 2). The increased protein expression of Hey-1 (in quiescent
compared to proliferating fibroblasts) was confirmed by immuno-
blotting analysis (Figure 4). These data indicate that the Notch
pathway is maintained in a less-activated or inactivated status in
proliferating human dermal fibroblasts whereas when these cells
become quiescent, they upregulate several Notch signaling
components. Thus, the status of Notch signaling appears to be
tightly correlated with the biological activity of fibroblasts.
‘‘Notch-Activated’’ Stromal Fibroblasts Inhibited Tumor
Growth/Invasion in a 3D Skin Melanoma Model
To address the potential biological relevance of Notch pathway
activation in fibroblasts, we tested the role of ‘‘Notch-activated’’
fibroblasts as stromal cells in modulating the growth and invasion/
migration of melanoma cells since it is well established that stromal
fibroblasts/CAFs play a critical role in regulating tumor growth
and metastasis. For this purpose, a 3D skin melanoma reconstruct
model, which resembles human physiological condition, was
utilized. Skin reconstructs consist of a ‘dermis’ of collagen with
embedded fibroblasts (FF2441-NICD1–GFP versus FF2441-GFP)
and an ‘epidermis’ of multi-layered keratinocytes with equal
number of metastatic melanoma cells (1205Lu) [16] [17]. After 14
days in culture, more 1205Lu cells were countable and many
1205Lu cells were able to invade into ‘dermis’ in which FF2441-
GFP were embedded. Strikingly, invasion/migration of melanoma
cells into ‘dermis’, in which FF2441-NICD1–GFP were embed-
ded, was remarkably suppressed, and less 1205Lu cells were
detectable (Figure 5). These data indicated that ‘‘Notch-activated’’
Figure 1. Deletion of Notch1 relieves its suppressive effect on cell growth and motility of MEFs. (A) Expression of full length Notch1 (250
Kd) and Trans-Membrane and Intra-Cellular domain (TMIC, 120 Kd) in Cre/lenti- versus GFP/Lenti-transduced Notch1Flox/Flox MEFs. Knock-out Notch1 in
Cre/lenti-transduced Notch1Flox/Flox MEFs was analyzed by Western blotting assay. b-actin was used as loading control. (B) Rate of cell growth of MEFs
in the presence 2% or absence of serum was measured by MTT assay. 5,000 cells/well were plated. Deletion of Notch1 promotes cell growth of MEFs.
(C) Deletion of Notch1 increases cell motility of MEFs. The migration of 15 randomly selected cell pairs was tracked over time (20 hours) by time-lapse
photography and velocity was calculated with software. (D) Left: Expression of endogenous full length Notch1 (250 Kd), TMIC (120 Kd) and
exogenous NICD (119 Kd) in MEFs was shown. Expression of activated Notch1 (NICD) was detected by specific antibody recognizing Val1744. Right:
Increased cell growth rate was reversed by reconstituted Notch1 activation in Notch1-deficint (Notch1 2/2) MEFs by NICD overexpression as
demonstrated by immunoblotting (b-actin was used as loading control). Cell growth rate of MEFs in the presence 2% or absence of serum was
measured by MTT assay. * P,0.05; ** P,0.01. Data are presented as mean 6 SD of three independently performed experiments in (B), (C), and (D).
doi:10.1371/journal.pone.0038811.g001
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fibroblasts inhibited growth of melanoma cells in ‘‘skin’’ and their
invasion into ‘dermis’.
Effect of Notch Signaling on Regulating WISP-1/CCN4
Expression in Fibroblasts
To understand the signaling mechanisms for the pronounced
effects of the Notch signaling on cell biology of fibroblasts, we
examined the gene expression profile of Notch pathway activation
in FF2441 cells using quantitative Human Notch Signaling
Pathway RT2 ProfilerTM PCR array, and found an approximately
6.5-fold increase in the gene expression of WISP-1/CCN4 in
FF2441-NICD1–GFP compared to FF2441-GFP cells (Figure 6A).
To validate the observed up-regulation of mRNA of WISP-1/
CCN4, we conducted immunoblotting analyses and confirmed an
up-regulated protein expression of WISP-1/CCN4 in FF2441-
NICD1–GFP compared to FF2441-GFP cells (Figure 6B). Con-
sistently, levels of WISP-1/CCN4 protein were down-regulated in
Notch1-deficient (Notch12/2) MEFs compared to Notch1Flox/Flox
MEFs as demonstrated by immunoblotting analyses (Figure 6C).
Transcriptional activation of WISP-1 gene was also tested in
FF2441-NICD1–GFP versus FF2441-GFP cells. Cells were
transduced with WISP1 promoter-Luc2/Lentivirus, control
RPL10PROM/Lentivirus and R01_PROM/Lentivirus, respec-
tively, and lucifease activities were measured 48 hours post-
transduction. As shown in Figure 6D, constitutive activation of
Notch1 significantly increased WISP-1 promoter activity in
fibroblasts compared with control. Thus, these experiments
identified WISP-1/CCN4 as one of the down-stream targets of
Notch pathway in fibroblasts. An in silico analysis of CSL binding
site in the promoter of WISP-1 gene did not reveal a matching
sequence, implicating that Notch indirectly regulates WISP-1 gene
expression. This is consistent with our findings showed below that
the regulation of WISP-1 by Notch is mediated by Wnt-11 in
fibroblasts.
Figure 2. Activated Notch1 induces pan-Notch activation in human fibroblasts. (A) FF2441 cells were transduced with either NICD1-GFP/
lenti or GFP/lenti. Two days after transduction, transductants were harvested and subjected to Western blot analysis. Expression of endogenous full
length Notch1 (250 Kd), TMIC (120 Kd) and exogenous NICD (119 Kd) in MEFs was shown. Expression of activated Notch1 (NICD) was detected by
specific antibody recognizing Val1744. b-actin was used as control. (B) Constitutive activation of Notch1 results in self-propagated pan-Notch
activation. Up-regulation of Notch receptors, ligands and target genes in FF2441-NICD1-GFP versus FF2441-GFP is observed by RT2 PCR Array. The
folds of increased gene expression in FF2441-NICD1-GFP compared to FF2441-GFP cells from two independently performed experiments were
shown.
doi:10.1371/journal.pone.0038811.g002
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WISP-1/CCN4 Suppresses Fibroblast Proliferation
Since constitutive activation of Notch1 pathway resulted in a
cell growth inhibition in fibroblasts, we sought to investigate a
potential role of WISP-1/CCN4 in mediating Notch-induced
growth control of fibroblasts. To examine for a potential biological
function of WISP-1/CCN4 in regulating cell growth in fibroblasts,
we performed MTT assay to test the effect of recombinant human
WISP-1/CCN4 on cell proliferation in FF2441 cells since WISP-
1/CCN4 is a soluble factor secreted by cells. Addition of
recombinant human WISP-1/CCN4 into the cell culture medium
significantly inhibited the growth rate of FF2441 cells, but only in
the presence of 10% FBS in the culture medium. In serum-free
medium, no significant inhibition was achievable. Two dosages of
WISP-1/CCN4 were tested, and both 10 ng/mL and 200 ng/mL
achieved comparable inhibition efficacy (Figure 7A). Similarly,
supplementation with recombinant human WISP-1/CCN4 sig-
nificantly slowed cell growth rate of Cre/MEFs in the presence of
10% of FBS, but not in the absence of serum. Only the higher dose
(200 ng/mL) of WISP-1/CCN4 was able to suppress cell growth
in Cre/MEFs, (Figure 7B), suggesting variable sensitivity of
different types of fibroblasts in responding to WISP-1/CCN4.
The serum-dependent effect of WISP-1/CCN4 on fibroblast
proliferation suggested that WISP-1/CCN4 interferes with growth
factor(s) in FBS that induce proliferation. However, WISP-1 does
not appear to induce a direct growth inhibition signal. In support
of this concept, we determined that addition of recombinant
WISP-1/CCN4 (200 ng/mL) inhibited serum-induced phosphor-
ylation of Erk1/2 (the signaling cascade delivered from the MAPK
pathway ultimately regulates the cell cycle machinery) in human
fibroblasts (Figure 7C, 7D) which were starved overnight with
serum-free medium and re-stimulated with FBS (10% in the
Figure 3. Effects of Notch activation and inhibition on human dermal fibroblast growth. Notch activation slows down cell growth rate of
fibroblasts. Proliferation of transduced FF2441 cells was determined by MTT assays (A). Activated Notch1 inhibited cell growth of fibroblasts. (B)
Inhibition of Notch activation by ectopic expression of DN-MAML-1 (upper) in FF2441-NICD-GFP cells relieves cell growth inhibition as measured by
MTT assay (lower). Data are presented as mean 6 SD of three independently performed experiments in (A) and (B). (C) Notch activation does not
induce cell apoptosis in fibroblasts. Cell apoptosis was determined by TUNEL assay. No obvious apoptotic cells were detectable in FF2441-NICD1-GFP
cells. Serum starvation-induced cells were used as positive control (FBS-).
doi:10.1371/journal.pone.0038811.g003
Table 1. Differential expression of genes involved in cell cycle control between NICD1-GFP/FF2441 and GFP/FF2441 cells.
Genes Fold Changes of Gene Expression in NICD1-GFP/FF2441 vs GFP/FF2441 Cells (Mean ± SD)
Cyclin D2 22.8860.08
Cyclin C 23.3660.12
Cyclin E1 24.7460.10
CDK 4 22.1860.08
CDK 6 26.0060.15
CDK 7 23.8660.06
CDK 8 22.2460.08
CDK Inhibitor 3 +2.2860.07
doi:10.1371/journal.pone.0038811.t001
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culture medium) in the presence of WISP-1/CCN4. These results
demonstrated a specific serum-dependent inhibitory effect of
WISP-1/CCN4 on the cell growth of fibroblasts that has not been
previously reported.
Inhibitory Effect of Notch Signaling on Human Fibroblast
Proliferation Is Partially Mediated by WISP-1/CCN4
Based on the findings detailed above, we hypothesized that the
inhibitory effect of Notch pathway activation on cell growth of
fibroblasts may be mediated through up-regulating the production
of WISP-1/CCN4 which, in turn, exerts its suppressive effect
through either autocrine or paracrine mechanism. To test this
hypothesis, we carried out siRNA-mediated gene silencing
experiments. Specific siRNA targeting human WISP-1/CCN4
and scrambled control siRNA were introduced into FF2441-
NICD1–GFP cells respectively by transient transfection. Knock-
down of WISP-1/CCN4 expression was confirmed by immuno-
blotting analyses 48 hours after transfection (Figure 8A). The
siRNAs-transfected FF2441-NICD1–GFP cells (wherin Notch is
constitutively activated) were subjected to MTT assay to examine
cell growth rate. We observed that specific interference with the
WISP-1/CCN4 expression partially, yet significantly relieves the
inhibitory effect of Notch activation on cell growth (Figure 8B).
The cell growth rate of FF2441-NICD1–GFP cells transfected
with specific WISP-1 siRNA, but not control siRNA, was partially
restored, suggesting that WISP-1/CCN4 is one of the critical
functional mediators of Notch signaling in regulating fibroblast
proliferation. These data demonstrated that inhibitory effects of
Notch signaling on human fibroblast proliferation are mediated in
part by WISP-1/CCN4. That is, WISP-1/CCN4 was demon-
strated to be one of functional down-stream targets of Notch
signaling in fibroblasts.
Notch Signaling-Induced WISP-1/CCN4 Expression Is
Wnt1-Independent, but Wnt11-Dependent in Fibroblasts
WISP-1/CCN4 was originally reported to be induced by Wnt1
[18]. However, our PCR array studies did not show that the levels
of Wnt1 gene in FF2441-NICD1–GFP are elevated compared to
that in FF2441-GFP cells. Immunoblotting analysis confirmed the
PCR array findings on Wnt1 expression (data not shown).
Alternatively, we observed that the expression of Wnt11 gene
was up-regulated .3-fold by Notch pathway activation
(Figure 9A). Immunoblotting analyses confirmed these findings
on the protein levels (Figure 9B). To explore whether Wnt11 is
responsible for the induction of WISP-1/CCN4 in human
fibroblasts, we blocked Wnt11 expression by siRNA approach
and investigated whether inhibition of Wnt-11 expression results in
the modulation of WISP-1/CCN4 expression in FF2441-NICD1–
GFP cells. As shown in Figure 9C, the upregulation of WISP-1/
CCN4 was reversed in FF2441-NICD1–GFP cells when Wnt11
was inhibited by siRNA. As a consequence, cell growth in FF2441-
NICD1–GFP cells was rescued (Figure 9D). These data strongly
suggest that Notch signaling-induced WISP-1/CCN4 expression
in human fibroblasts is mediated through Wnt11, but not Wnt1.
Thus, these data identified a novel Wnt1-independent, but Wnt11-
dependent mechanism for the induction of WISP-1/CCN
Figure 4. The Notch pathway is maintained in a less-activated
or inactivated status in proliferating human dermal fibro-
blasts. The increased expression of Hey-1 protein in quiescent
fibroblasts compared to proliferating fibroblasts was demonstrated by
immunoblotting analysis. b-actin was used as loading control.
doi:10.1371/journal.pone.0038811.g004
Table 2. Notch pathway is activated in quiescent fibroblasts.
Genes Fold Increase of Gene Expression (Quiescent/Proliferating Cells) (Mean ± SD) P-Value
Notch1 1.36±0.05 ,0.01
Notch2 0.3860.04 .0.05
Notch3 1.82±0.21 ,0.01
Notch4 2.12±0.46 ,0.01
Jagged-1 0.7860.08 .0.05
Jagged-2 3.46±0.55 ,0.01
Dll-1 2.02±0.40 ,0.01
Hes-1 0.7860.06 .0.05
Hey-1 1.56±0.15 ,0.01
HeyL 0.2460.03 .0.05
Presenilin-1 0.5660.05 .0.05
TACE 2.34±0.32 ,0.01
doi:10.1371/journal.pone.0038811.t002
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expression in fibroblasts and thereby, for the first time, established
a linkage between Notch, Wnt11 and WISP-1/CCN4.
Discussion
Cell cycle and cell growth of fibroblasts are tightly controlled. In
normal uninjured tissues, resident fibroblasts are maintained in a
relatively quiescent state. When tissue is injured or undergoing
tumorigenesis, quiescent resident fibroblasts are stimulated by
inflammatory factors or tumor cell-derived stimulatory factors,
and activated. The involvement of Notch signaling in regulating
cell growth of fibroblasts was previously mostly unexplored. A few
prior studies provide inconsistent results with respect to Notch’s
role in regulating the fibroblast cell cycle. For example, a study
showed that Notch1 activation promotes the G1-S transition of the
cell cycle by inducing the expression of Skp2 and the consequent
degradation of the CDK inhibitor p27 in 3T3 mouse fibroblasts
[19]. In contrast, activation of Notch signaling via either
overexpression of NICD or stabilization of NICD by ablation of
SEL-10 (Fbxw7), a negative regulator of Notch signaling, resulted
in cell cycle arrest and apoptosis in mouse embryonic fibroblasts
(MEFs) [20]. The results of the latter study are consistent with our
findings. In other prior work also consistent with our findings, it
was reported that inhibition of Notch signaling by soluble forms of
the Dll1 and Jagged1 ligands was able to induce fibroblast growth
factor receptor (FGFR)-dependent transformation of NIH 3T3
fibroblasts in vitro [21]. These studies and ours point to Notch
signaling as a negative regulator or ‘break’ on fibroblast cell
growth.
An overall assessment of the prior literature and our novel
findings appears to indicate that the status of Notch signaling is
tightly correlated with the growth characteristics of fibroblasts.
Deletion or inhibition of Notch1 signaling exempts fibroblasts
from at least one growth control mechanism and cells proliferate
faster as occurred in Notch1-deficient (Notch12/2) MEFs, whereas
enforced activation of the Notch pathway inhibits cell growth of
human dermal fibroblasts. It is, therefore, postulated that
deregulation of Notch signaling may be involved in the
pathophysiology of some disorders in which fibroblasts are
involved. Our study employing Notch-engineered fibroblasts as
stromal cells for modulating tumor cell growth/invasion provides
an example to demonstrate the biological relevance of Notch
activation in fibroblasts. It also suggests a paracrine effect of
‘‘Notch-activated’’ fibroblasts on other types of cells. In this
regard, we have recently demonstrated that Notch-induced WISP-
1 expression in fibroblasts is responsible for the inhibition of
Figure 5. Inhibitory effects of ‘‘Notch-activated’’ fibroblasts as stromal cells on melanoma cell growth and invasion in 3D model. (A)
Representative images of H&E staining of sections of 3D skin melanoma model. (B) Melanoma cell growth in 3D skin model. Significantly decreased
melanoma cells were observed in 3D reconstructs in which FF2441-NICD1-GFP cells were embedded in collagen. (C) Decreased invasion into ‘dermis’
by melanoma cells in 3D skin reconstructs in which FF2441-NICD1-GFP cells were embedded. All data are calculated based on that from 5 randomly
selected LPF/section and totally 10 sections per group.
doi:10.1371/journal.pone.0038811.g005
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melanoma growth [22]. Our work implies that Notch pathway is
likely inactivated in CAFs of tumors, such as melanoma, since
‘‘Notch-activated’’ fibroblasts suppress melanoma cell growth/
invasion. This new concept has not been previously tested. Future
studies will be required to determine the potential correlation
between the status of the Notch activation and biological function
of CAFs in tumors.
Our work also revealed a previously unexplored concept.
Constitutive activation of Notch1 pathway induces activation of
pan-Notch pathways. It indicates existence of a mechanism for
Notch signaling undergoing ‘‘self propagation’’. It is, however,
unclear whether this is a unique phenomenon in fibroblasts, or it is
a fairly universal mechanism for Notch signaling in other cell
types. Although more studies are required, the latter appears to be
the case, since we have found that overexpression of NICD1 in
other cells, for example, human melanocytes, can induce the
expression of several Notch ligands and receptors (ZL unpublished
data). Ross et al. also observed that activation of Notch signaling
induces Jagged-1 expression in C2C12 and NIH3T3 cells [23].
However, unlike the concept of self-propagation of initial signal, as
suggested by our data, it was speculated that the induced Jagged-1
has no apparent authorizing effects on Notch signaling but can
promote signaling in naı¨ve cells. That is, it was previously
attributed to a mechanism through which Notch signaling can be
relayed from cell to cell.
A previously unknown signaling mechanism discovered by this
work is the identification of WISP-1/CCN4 as one of functional
mediators in delivery of the inhibitory effect of Notch signaling on
fibroblast proliferation. The data not only locate WISP-1/CCN4
as a down- stream target gene of Notch signaling, but also unveil a
new target for potential therapeutic manipulation. The molecular
mechanism regarding how WISP-1/CCN4 exerts its serum-
dependent inhibitory effect on cell growth of fibroblasts remains
an open question for future study. WISP-1 has been reported to
function as a pro-mitogenic factor in mediating TNF-a-induced
cardiac fibroblast proliferation [24]. The reason as to why WISP-1
exerts paradoxical biological effects remains unknown. Presum-
ably, it is determined by other cooperative signaling(s) induced by
up-stream signal, because TNF-a stimulates cell growth of cardiac
fibroblasts whereas Notch signaling suppresses fibroblast prolifer-
ation. Alternatively, it is simply cell type-dependent. It has been
reported that WISP-1 binding to human skin fibroblasts is
mediated through interaction with cell surface decorin and
biglycan [25]. It may prove worthwhile to investigate whether
decorin and biglycan are responsible for mediating WISP-1’s
action on fibroblast growth inhibition.
Figure 6. Notch pathway activation induces expression of WISP-1/CCN4 in fibroblasts. (A) Levels of mRNA of WISP-1/CCN4 were up-
regulated in FF2441-NICD1-GFP compared to FF2441-GFP cells. Data are from RT2 PCR Array and presented as fold changed in gene expression by
setting levels of genes in FF2441-GFP as ‘‘1’’. Data are presented as mean 6 SD of three independently performed experiments. (B) Expression of
WISP-1/CCN4 protein was up-regulated by Notch pathway activation in fibroblasts. Expression of WISP-1/CCN4 in FF2441-NICD1-GFP versus FF2441-
GFP and untreated F2441 (2) cells was analyzed by Western blotting assay. b-actin was used as loading control. (C) Expression of WISP-1/CCN4
protein was down-regulated in Notch12/2 MEFs. Expression of WISP-1/CCN4 in Notch12/2 versus Notch1Flox/Flox MEFs (both untreated (2) and GFP/
lenti-transduced) was analyzed by Western blotting assay. b-actin was used as loading control. (D) Increased WISP-1 promotor-driven luciferase
activity in FF2441-NICD1-GFP compared to FF2441-GFP cells. Data are presented as mean 6 SD of three independently performed experiments.
doi:10.1371/journal.pone.0038811.g006
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WISP-1 was initially identified as a Wnt1 responsive target [18],
and belongs to the CCN family, which includes connective tissue
growth factor (CTGF), cysteine-rich-61 (CYR61), and nephro-
blastoma overexpressed (NOV) [26]. NOV (CCN3) has been
shown to associate with Notch1 extracellular domain and exert a
positive effect on Notch signaling in inhibiting myoblasts
differentiation [27], while our findings reveal that WISP-1/
CCN4 functions as a down-stream target of Notch signaling in
fibroblasts. These studies provide representative examples to
demonstrate the interaction between Notch and CCN family.
Until now, Wnt1 is the only member in the Wnt family known to
induce WISP-1. Wnt4 is unable to up-regulate WISP-1 expression
in the same experimental setting as Wnt1 does [18]. The promoter
of WISP-1 has been shown to be activated by both Wnt 1 and b-
catenin expression. TCF/LEF sites played a minor role, whereas
the CREB site played an important role in the transcriptional
activation [28]. Our observation that WISP-1 responds to Wnt11,
but not Wnt1, mediates the observed effects, expands the scope of
the Wnt family members involved in regulating WISP-1 and
suggests that the Wnt/WISP axis may be cell type-specific.
However, unlike Wnt1, which is known to activate the canonical
Wnt/b-catenin pathway, Wnt11 is classified as a non-canonical
signaling. Wnt11 is essential for the development of the heart and
kidney [29–32], and is also implicated in cancer [33–36]. Wnt11
signaling is thought to function in part by inhibiting the activity of
the b-catenin-dependent Wnt pathway [37]. We have not
evaluated the activity of b-catenin in response to Wnt11 signaling
in this study. Future work will be required to elucidate the Wnt11
down-stream pathway responsible for regulating WISP-1 expres-
sion in fibroblasts.
In summary, we herein report an inhibitory role of Notch
signaling in regulating cell growth of fibroblasts, which is partially
mediated by the induction of WISP-1/CCN4 through a Wnt11-
dependent, but Wnt1-independent mechanism. Our study estab-
lishes a functional linkage between Notch, Wnt11 and WISP-1/
CCN4, and suggests a central role for Notch in coordination
between these. The new findings lead us to postulate that Notch
signaling in fibroblasts could potentially be implicated in some
pathologic states featuring fibroblast growth deregulation.
Methods
Reagents
Recombinant human WISP-1/CCN4 was purchased from R &
D Systems (Minneapolis, MN). SDS-polyacrylamide gels were
obtained from Invitrogen (Carlsbad, CA). X-ray films were
purchased from Kodak (Rochester, NY). All other chemicals and
solutions were from Sigma–Aldrich (St. Louis, MO) unless
otherwise indicated.
Mice and Cells
Notch1Flox/Flox mice were established as described previously
[38]. Animal experiments were approved by the Institute Animal
Care and Use Committee of the University of Miami (IACUC
#10-228). Primary human dermal fibroblasts (FF2441) were
initiated as explant cultures from trypsin-treated and epidermis-
Figure 7. Effect of WISP-1/CCN4 on cell growth of fibroblasts. Supplementation of exogenous recombinant human WISP-1/CCN4 slowed
down cell growth of FF2441 cells (A) and Cre/MEFs (B). Proliferation of cells was determined by MTT assays. 5,000 FF2441 cells/well and 2,000 Cre/
MEFs/well were plated respectively. Data are presented as mean 6 SD of three independently performed experiments. (C) Addition of 200 ng/mL of
recombinant human WISP-1/CCN4 inhibited serum-induced phosphorylation of Erk1/2 in FF2441 cells. Total amount of Erk1/2 was used as control.
Time course of phosphorylation of Erk1/2. Serum starved cells were stimulated with 10% serum in the presence of WISP-1/CCN4 for varying times.
Autophotographs of Western blots were quantified by computerized densitometry. pERK1/2 signals were normalized to total ERK levels and
unstimulated (time ‘‘0’’) samples were set as ‘‘1’’. Relative index of pErk1/2 compared to unstimulated samples from three independent Western blots
was plotted. (D) A representative Western blot was shown.
doi:10.1371/journal.pone.0038811.g007
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stripped neonatal foreskin [14] and cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 20 mM
L-glutamine (Invitrogen), 8 mM HEPES and 10% FBS (Hyclone,
Logan, UT). The MEFs were isolated from Notch1Flox/Flox mice
using the method described previously [39] and cultured in
DMEM with glutamine, HEPES and 10% FBS. All experiments
were performed with MEFs at passage 3–10. Human metastatic
melanoma cell line, 1205Lu (ATCC, #CRL-2812), was cultured
in 2% FBS-W489 medium as described [14]. All cells were
incubated at 37uC in 98% humidified air containing 5% CO2.
Recombinant Lentiviruses and Retroviruses
Methods for generation of GFP/lenti and NICD1–GFP/lenti
were described previously [15]. Cre/lenti was constructed by
inserting Cre gene into pHX’ lentiviral vector [15]. Production of
pseudotyped lentivirus was achieved by co-transfecting 293 T cells
(ATCC # CRL-11268TM) with three plasmids as described [15].
The lentiviruses collected 48 hours post-transfection displayed
titers of around 107 transducing units/ml in NIH/3T3 cells
(ATCC, #CRL-1658TM). Retroviral vector MAML305/pBabe
(DN-MAML1 (Myc-tagged)) and empty pBabe vector (Mock) were
described previously [40]. To infect target cells by lentiviruses and
retroviruses, cells were exposed six hours to virus with MOI
(multiplicity of infection) 5 in the presence of 4 mg/ml polybrene.
Cells were then washed, cultured with regular complete medium
for two additional days, and analyzed for protein expression by
Western blot or pooled for subsequent analysis as indicated in
individual experiments.
Figure 8. WISP-1/CCN4 is partially responsible for mediating the inhibitory effect of Notch signaling on fibroblast proliferation. (A)
siRNA-mediated knocking-down WISP-1/CCN4 expression in human fibroblasts. Expression of WISP-1/CCN4 in siRNA-transfected versus non-targeting
control siRNA-transfected or untransduced FF2441-NICD1-GFP cells was analyzed by Western blotting assay. b-actin was used as loading control. (B)
Blockage of WISP-1/CCN4 expression relieved Notch’s inhibitory effect on cell growth of fibroblasts. Proliferation of siRNA-transfected versus non-
targeting control siRNA-transfected FF2441-NICD1-GFP cells was determined by MTT assays. 2,000 cells/well were plated. Data are presented as mean
6 SD of three independently performed experiments.
doi:10.1371/journal.pone.0038811.g008
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PCR Array
The Human Notch Signaling Pathway RTu ProfilerTM PCR
Array (# PAHS-059, SABiosciences, Frederick, MD) and Human
Cell Cycle RTu ProfilerTM PCR Array (#PAHS-020) quantita-
tively profiles the expression of 84 genes involved in Notch
signaling and 84 genes involved in cell cycle control, respectively.
Total RNA was extracted from cells using TrizolH (Invitrogen) and
cDNA was synthesized using RTu First Strand Kits (SABios-
ciences). PCR array was carried out according to the manufac-
turer’s protocol. The threshold cycle (Ct) values were used to plot a
standard curve. All samples were normalized to the relative levels
of b-actin, and results are expressed as fluorescence intensity in
relative levels.
Immunoblotting
Western blotting was performed as described [15]. Membranes
were probed with Abs to Notch1 (a rabbit polyclonal antiserum
directly against residues 1759–2095) [15], cleaved/activated
Notch1 (an antibody recognizing Val1744 (ab52301, Abcam,
Cambridge, MA)), phospho-MAPK (#9106, Cell Signaling
Technologies, Danvers, MA), p44/42 MAPK (#9102, Cell
Signaling Technologies), WISP-1/CCN3 (H-57, sc-25441, Santa
Cruz Biotechnologies, Santa Cruz, CA), Wnt-11 (sc-50360, Santa
Cruz Biotechnologies), Hey-1 (GTX42614, GeneTex, Irvine, CA)
or b-actin (AC-15, Abcam). Myc-tagged DN-MAML1 was
detected on Western blot by 9-B11 Ab (Santa Cruz). This was
followed by probing with HRP-conjugated second Ab (Jackson
Immunoresearch, PA) and subjected to ECL (Amersham Biosci-
ences, Piscataway, NJ). Membranes were stripped and re-blotted
Figure 9. Notch-induced WISP-1/CCN expression is Wnt11-dependent in the fibroblasts. (A) Levels of mRNA of Wnt11 were up-regulated
in FF2441-NICD1-GFP cells compared to FF2441-GFP cells. Data are from RT2 PCR Array and presented as fold changed in gene expression by setting
levels of genes in FF2441-GFP as ‘‘1’’. (B) Expression of Wnt11 protein was up-regulated by Notch pathway activation in fibroblasts. Expression of
Wnt11 in FF2441-NICD1-GFP versus FF2441-GFP and untreated FF2441 (2) cells was analyzed by Western blotting assay. b-actin was used as loading
control. (C) Blockage of Wnt11 expression resulted in decreased expression of WISP-1/CCN expression. siRNA-mediated knocking-down Wnt11
expression in human fibroblasts. Expression of WISP-1/CCN4 in wnt11siRNA-transfected versus non-targeting control siRNA-transfected FF2441-
NICD1-GFP cells was analyzed by Western blotting assay. b-actin was used as loading control. (D) Blockage of Wnt11 expression relieved Notch’s
inhibitory effect on cell growth of fibroblasts. Cell proliferation of wnt11 siRNA-transfected-, non-targeting control siRNA-transfected- and their
‘‘parental’’ FF2441-NICD1-GFP was determined by MTT assays. 2,000 cells/well were plated. Data are presented as mean6 SD of three independently
performed experiments.
doi:10.1371/journal.pone.0038811.g009
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as required in the individual experiment. To quantify the bands in
the blots, autophotographs of Western blots were scanned by
computerized densitometry (Molecular Dynamics).
Construction of WISP1 Promoter-Luc2/Lentiviral Vector
and Luciferase Assay
Plasmids containing WISP1 promoter-Luc2 fragment (WISP1
PROM_01, ID: S113793) and two control fragments
(RPL10PROM_01, ID: S108908, and R01_PROM, ID:
S190001) were purchased from SwitchGear Genomics (Menlo
Park, CA). WISP1 PROM_01 was digested by SacI and SalI, and
both RPL10PROM_01 and R01_PROM were digested by MulI
and SalI, respectively. ,2.1 kb WISP1 promoter-Luc2 and two
control fragments were isolated, blunted and inserted into SmaI
cut pHX’ vector. Cells were transduced with WISP1 promoter-Luc2/
Lentivirus, control RPL10PROM/Lentivirus and R01_PROM/
Lentivirus, respectively. 48 hours post-transduction, 26104 cells/
well in 96 well plates (triplicates) were measured for luciferase
activity. Luciferase assays were performed using Steady-GloH
Luciferase Assay kit (Promega, Madison, WI) according to the
manufacturer’s protocol. Luciferase activity measurement was
corrected by subtraction of readings of controls.
MTT Assay
Cell growth was measured by MTT assay. MTT cell
proliferation kits were purchased from BioVision Technologies
(Exton, PA). Cell proliferation was measured according to the
manufacturer’s protocol. 2,000–5,000 cells/well were cultured in
96-well plate and cultured in DMEM with or without FBS as
indicated in individual experiment. Samples were assayed in
triplicate and experiments were repeated three times.
Apoptosis Assay
Cell apoptosis was detected by TUNEL based ApopTagH kit
(S7100) from Chemicon (Billerica, MA) according to the
manufacturer’s protocol. Briefly, cells fixed with 4% formaldehyde
were pre-treated with 3% H2O2 for 5 minutes at room temper-
ature followed by washing with PBS. After incubation with
equilibration buffer for 15 minutes at room temperature and TdT
enzyme at 37uC for 60 minutes, cells were treated with stop/wash
buffer for 10 minutes after being agitated for 15 seconds at room
temperature, followed by washing with PBS. Cells were then
incubated with anti-digoxigenin conjugate for 30 minutes at room
temperature followed by washing with PBS. Apoptotic cells were
stained with colorimetric substrates diaminobenzidine (DAB).
Serum-starved cells (72 hours) were used as positive control.
In vitro Cell Motility Assay and Time-Lapse Photography
To measure cell motility in vitro, MEF/Cre and MEF/GFP cells
were cultured overnight to sub-confluence in 24-well plate. A gap
was created by scratching cells with a standard tip. Velocity of
fibroblast migration (mM per minute) was recorded using time-
lapse photography at 10-minute intervals, for 20 hours. Fifteen
randomly selected individual cells per well were tracked, and data
were analyzed by ImagePro 5.0 software (MediaCybernetics,
Silver Spring, MD).
In vitro Three-Dimensional (3D) Skin Melanoma Model
3D skin melanoma model was prepared as described [16,17]. A
total of 3 mL of fibroblasts (FF2441-NICD1–GFP versus FF2441-
GFP, 7.56104cells/mL) in a 4:1 mixture of bovine type I collagen
(Organogenesis, Canton, MA): MatrigelH (BD Bioscience) was
added to each insert of tissue culture trays (Organogenesis) and
were allowed to constrict in DMEM with 10% FBS for 7 days at
37uC. For epidermal reconstruction, human keratinocytes, isolated
from human epidermis of neonatal foreskins and cultured as
described, [17,41] were mixed with human metastatic melanoma
cells (1205Lu) at a ratio of 5:1 in epidermal growth medium
composed of three parts DMEM and 1 part Ham’s F-12
supplemented with 2.4 M CaCl2, 0.18 mM adenine, 4 mM
glutamine, 10 mg/ml selenium, 10 mM ethanolamine, 0.1 mM
O-phosphoryl ethanolamine, 10 mg/mL insulin, 10 mg/mL trans-
ferrin, 20 pM tri-iodothyronine, 0.5 mg/mL hydrocortisone and
4 pM progesterone. A total of 56106 cells were seeded on each
contracted collagen gel. Cultures were kept submerged in medium
containing 1 ng/mL EGF and 0.1% dialysed newborn calf serum
for 2 days, then in 0.2 ng/mL EGF and 0.1% dialysed newborn
calf serum for another 2 days, and then were raised to the air–
liquid interface via feeding from below with medium containing
2% dialysed newborn calf serum. After 14 days, skin reconstructs
were fixed with 4% paraformaldehyde and were embedded in
paraffin. Cell growth of melanoma cells was measured by counting
melanoma cell number per low power field (LPF, X10). The
invasive capacity of melanoma cells was determined by measuring
the % of area of melanoma cells occupied in a given LPF based on
morphological evaluation using H&E staining. Data are calculated
based on that from 5 randomly selected fields/section and totally
10 sections per group.
siRNA Gene Silencing
Short interfering RNA (siRNA) targeting the human form of
WISP-1/CCN4 (sc-39335), Wnt-11 (sc-41120) and control,
nontargeting siRNA (sc-37007), along with Transfection Reagent
(sc-29528), siRNA Transfection Medium (sc-36868) and siRNA
Dilution Buffer (sc-29527) were purchased from Santa Cruz
Biotechnology. The experiments were performed according to the
manufacturer’s protocol.
Statistical Analysis
All data is expressed as mean 6 SD. Statistical analysis was
carried out using paired Student’s t-test. Values considered
statistically significant were P,0.05.
Acknowledgments
We thank Dr. M. Herlyn for FF2441 cells. We also thank Dr. A. J.
Capobianco for the critical reading of this manuscript and Dr. George
McNamara for assistance with the time-lapse photography and data
analyses.
Author Contributions
Conceived and designed the experiments: ZL OCV. Performed the
experiments: YL YT MX JZ. Analyzed the data: ZL YL YT MX. Wrote
the paper: ZL OCV. Provided Notch1 Flox/Flox mice for this study: FR.
References
1. Becker V, Muller G (1998) Biology of fibroblasts. Clinical and Experimental
Nephrology 2: 295–301.
2. Ingber DE (2002) Cancer as a disease of epithelial-mesenchymal interactions
and extracellular matrix regulation. Differentiation 70: 547–560.
3. Lynch CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell
communication. Differentiation 70: 561–573.
4. Midwood KS, Williams LV, Schwarzbauer JE (2004) Tissue repair and the
dynamics of the extracellular matrix. Int J Biochem Cell Biol 36: 1031–1037.
5. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor
stroma generation and wound healing. N Engl J Med 315: 1650–1659.
6. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-
promoting cell type. Cell Cycle 5: 1597–1601.
Notch Regulates Fibroblasts via WISP-1
PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38811
7. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G (1988) Smooth-
muscle differentiation in stromal cells of malignant and non-malignant breast
tissues. Int J Cancer 41: 707–712.
8. Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, et al. (2003) Bone-marrow-
derived myofibroblasts contribute to the cancer-induced stromal reaction.
Biochem Biophys Res Commun 309: 232–240.
9. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its
implications for fibrosis. J Clin Invest 112: 1776–1784.
10. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate
control and signal integration in development. Science 284: 770–776.
11. Mumm JS, Kopan R (2000) Notch signaling: from the outside in. Dev Biol 228:
151–165.
12. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour
suppressor? Nat Rev Cancer 3: 756–767.
13. Maillard I, Pear WS (2003) Notch and cancer: best to avoid the ups and downs.
Cancer Cell 3: 203–205.
14. Meier F, Nesbit M, Hsu MY, Martin B, Van Belle P, et al. (2000) Human
melanoma progression in skin reconstructs : biological significance of bFGF.
Am J Pathol 156: 193–200.
15. Balint K, Xiao M, Pinnix CC, Soma A, Veres I, et al. (2005) Activation of
Notch1 signaling is required for beta-catenin-mediated human primary
melanoma progression. J Clin Invest 115: 3166–3176.
16. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, et al. (2008)
Downregulation of CCN3 expression as a potential mechanism for melanoma
progression. Oncogene 27: 2552–2560.
17. Hsu MY, Shih DT, Meier FE, Van Belle P, Hsu JY, et al. (1998) Adenoviral
gene transfer of beta3 integrin subunit induces conversion from radial to vertical
growth phase in primary human melanoma. Am J Pathol 153: 1435–1442.
18. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, et al. (1998)
WISP genes are members of the connective tissue growth factor family that are
up-regulated in wnt-1-transformed cells and aberrantly expressed in human
colon tumors. Proc Natl Acad Sci U S A 95: 14717–14722.
19. Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, et al. (2005)
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription
and p27 Kip1 degradation. J Exp Med 202: 157–168.
20. Ishikawa Y, Onoyama I, Nakayama KI, Nakayama K (2008) Notch-dependent
cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7.
Oncogene 27: 6164–6174.
21. Urs S, Roudabush A, O’Neill CF, Pinz I, Prudovsky I, et al. (2008) Soluble forms
of the Notch ligands Delta1 and Jagged1 promote in vivo tumorigenicity in
NIH3T3 fibroblasts with distinct phenotypes. Am J Pathol 173: 865–878.
22. Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, et al. (2011)
Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth
by upregulating WISP-1. Oncogene 30: 4316–4326.
23. Ross DA, Kadesch T (2004) Consequences of Notch-mediated induction of
Jagged1. Exp Cell Res 296: 173–182.
24. Venkatachalam K, Venkatesan B, Valente AJ, Melby PC, Nandish S, et al.
(2009) WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis
factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits
TNF-alpha-induced cardiomyocyte death. J Biol Chem 284: 14414–14427.
25. Desnoyers L, Arnott D, Pennica D (2001) WISP-1 binds to decorin and
biglycan. J Biol Chem 276: 47599–47607.
26. Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, et al. (2001) A novel
variant of WISP1 lacking a Von Willebrand type C module overexpressed in
scirrhous gastric carcinoma. Oncogene 20: 5525–5532.
27. Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, et al. (2002)
The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with
Notch1 extracellular domain and inhibits myoblast differentiation via Notch
signaling pathway. J Biol Chem 277: 29399–29405.
28. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-
1- and beta-catenin-responsive oncogene. Genes Dev 14: 585–595.
29. Pandur P, Lasche M, Eisenberg LM, Kuhl M (2002) Wnt-11 activation of a non-
canonical Wnt signalling pathway is required for cardiogenesis. Nature 418:
636–641.
30. Majumdar A, Vainio S, Kispert A, McMahon J, McMahon AP (2003) Wnt11
and Ret/Gdnf pathways cooperate in regulating ureteric branching during
metanephric kidney development. Development 130: 3175–3185.
31. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, et al. (2007) Biphasic role
for Wnt/beta-catenin signaling in cardiac specification in zebrafish and
embryonic stem cells. Proc Natl Acad Sci U S A 104: 9685–9690.
32. Zhou W, Lin L, Majumdar A, Li X, Zhang X, Liu W, et al. (2007) Modulation
of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-
mediated transcriptional activation of TGFbeta2. Nat Genet 39: 1225–1234.
33. Kirikoshi H, Sekihara H, Katoh M (2001) Molecular cloning and character-
ization of human WNT11. Int J Mol Med 8: 651–656.
34. Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW (2004) Wnt11 signaling
promotes proliferation, transformation, and migration of IEC6 intestinal
epithelial cells. J Biol Chem 279: 26707–26715.
35. Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, et al. (2004) Analysis of
Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the
androgen receptor. Cancer Res 64: 7918–7926.
36. Lin Z, Reierstad S, Huang CC, Bulun SE (2007) Novel estrogen receptor-alpha
binding sites and estradiol target genes identified by chromatin immunoprecip-
itation cloning in breast cancer. Cancer Res 67: 5017–5024.
37. Railo A, Nagy II, Kilpelainen P, Vainio S (2008) Wnt-11 signaling leads to
down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways
and promotes viability in the CHO-K1 cells. Exp Cell Res 314: 2389–2399.
38. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. (1999) Deficient T
cell fate specification in mice with an induced inactivation of Notch1. Immunity
10: 547–558.
39. Hogan B, Beddington R, Costantini F, Lacey E Manipulating the Mouse
Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press,
Plainview, N.Y).
40. Liu ZJ, Xiao M, Balint K, Soma A, Pinnix CC, et al. (2006) Inhibition of
endothelial cell proliferation by Notch1 signaling is mediated by repressing
MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20:
1009–1011.
41. Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, et al. (2006)
CCN3 controls 3D spatial localization of melanocytes in the human skin
through DDR1. J Cell Biol 175: 563–569.
Notch Regulates Fibroblasts via WISP-1
PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e38811
